ClinVar Miner

Submissions for variant NM_003327.4(TNFRSF4):c.494T>C (p.Ile165Thr)

gnomAD frequency: 0.00090  dbSNP: rs150407012
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000694602 SCV000823053 likely benign Combined immunodeficiency due to OX40 deficiency 2025-01-30 criteria provided, single submitter clinical testing
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago RCV000694602 SCV002495995 uncertain significance Combined immunodeficiency due to OX40 deficiency 2021-08-16 criteria provided, single submitter clinical testing TNFRSF4 NM_003327.3 exon 5 p.Ile165Thr (c.494T>C): This variant has not been reported in the literature but is present in 0.2% (24/15282) of Latino alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/1-1212082-A-G?dataset=gnomad_r3). This variant is present in ClinVar (Variation ID: 573043). Evolutionary conservation suggests that this variant does not impact the protein; computational predictive tools are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain.
CeGaT Center for Human Genetics Tuebingen RCV003411616 SCV004126897 likely benign not provided 2022-04-01 criteria provided, single submitter clinical testing TNFRSF4: BP4

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.